• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4052个供卵周期中与卵巢刺激和取卵相关的并发症

Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.

作者信息

Bodri Daniel, Guillén Juan José, Polo Ana, Trullenque Marta, Esteve Carolina, Coll Oriol

机构信息

Clínica EUGIN, Calle Entença 293-295, 08029 Barcelona, Spain.

出版信息

Reprod Biomed Online. 2008 Aug;17(2):237-43. doi: 10.1016/s1472-6483(10)60200-3.

DOI:10.1016/s1472-6483(10)60200-3
PMID:18681998
Abstract

A retrospective study was conducted in a private infertility centre to evaluate the rate of complications in a large oocyte donation programme. A total of 4052 oocyte retrievals were performed between January 2001 and October 2007. Altogether, 1238 cycles (30.6%) were stimulated with the use of gonadotrophin-releasing hormone (GnRH) agonists and in 2814 cycles (69.4%) the GnRH antagonist protocol was used. The GnRH antagonist treated cycles were triggered with human chorionic gonadotrophin (HCG) or a GnRH agonist in 1295 and 1519 cycles, respectively. Complications related to oocyte retrieval occurred in 17 patients (0.42%) (intra-abdominal bleeding: n = 14, severe pain: n = 2, ovarian torsion: n = 1). Fourteen of these were hospitalized (0.35%) and six donors (0.15%) required surgical intervention. Pelvic infections, injury to pelvic structures or anaesthesiological complications were not observed in this series. Moderate/severe ovarian hyperstimulation syndrome (OHSS) occurred in 22 donors; 11 required hospital admission and 11 were managed on an outpatient basis. All cases were related to HCG triggering (0.87%). Serious complications related to oocyte retrieval occurred at a low rate in healthy young donors. The risk of OHSS can be substantially reduced by specific stimulation protocols, which include GnRH agonist triggering. Prospective oocyte donors should be adequately counselled about the risks related to egg donation.

摘要

在一家私立不孕不育中心进行了一项回顾性研究,以评估大型卵母细胞捐赠项目中的并发症发生率。2001年1月至2007年10月期间共进行了4052次取卵操作。总共1238个周期(30.6%)使用促性腺激素释放激素(GnRH)激动剂进行刺激,2814个周期(69.4%)使用GnRH拮抗剂方案。GnRH拮抗剂治疗的周期分别在1295个和1519个周期中用人绒毛膜促性腺激素(HCG)或GnRH激动剂触发。与取卵相关的并发症发生在17例患者中(0.42%)(腹腔内出血:n = 14,严重疼痛:n = 2,卵巢扭转:n = 1)。其中14例住院(0.35%),6例捐赠者(0.15%)需要手术干预。本系列中未观察到盆腔感染、盆腔结构损伤或麻醉并发症。22例捐赠者发生中度/重度卵巢过度刺激综合征(OHSS);11例需要住院治疗,11例在门诊处理。所有病例均与HCG触发有关(0.87%)。健康年轻捐赠者中与取卵相关的严重并发症发生率较低。通过包括GnRH激动剂触发在内的特定刺激方案,OHSS的风险可大幅降低。应向潜在的卵母细胞捐赠者充分咨询与卵子捐赠相关的风险。

相似文献

1
Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.4052个供卵周期中与卵巢刺激和取卵相关的并发症
Reprod Biomed Online. 2008 Aug;17(2):237-43. doi: 10.1016/s1472-6483(10)60200-3.
2
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.在促性腺激素释放激素拮抗剂治疗的卵母细胞捐赠周期中使用人绒毛膜促性腺激素或促性腺激素释放激素激动剂进行触发:一项大型回顾性队列研究的结果
Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25.
3
The incidence of both serious and minor complications in young women undergoing oocyte donation.接受卵母细胞捐赠的年轻女性中严重和轻微并发症的发生率。
Fertil Steril. 2008 Dec;90(6):2165-71. doi: 10.1016/j.fertnstert.2007.10.065. Epub 2008 Feb 4.
4
The prevention of ovarian hyperstimulation syndrome.卵巢过度刺激综合征的预防
J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5.
5
Predictive factors for oocyte retrieval failure in controlled ovarian hyperstimulation protocols: a retrospective observational cohort study.控制性卵巢刺激方案中卵母细胞取卵失败的预测因素:一项回顾性观察队列研究。
Reprod Biol Endocrinol. 2015 Jun 2;13:53. doi: 10.1186/s12958-015-0052-x.
6
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.在拮抗剂辅助生殖技术周期中,促性腺激素释放激素激动剂与绒毛膜促性腺激素用于触发排卵的比较。
Cochrane Database Syst Rev. 2010 Nov 10(11):CD008046. doi: 10.1002/14651858.CD008046.pub2.
7
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险:一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.
8
Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.在人绒毛膜促性腺激素释放激素激动剂扳机时给予低剂量人绒毛膜促性腺激素与在有发生卵巢过度刺激综合征高危风险的妇女中在 35 小时后给予相比 - 一项前瞻性随机双盲临床试验。
J Ovarian Res. 2019 Jan 26;12(1):8. doi: 10.1186/s13048-019-0483-7.
9
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.促性腺激素释放激素激动剂扳机后改良黄体支持在高风险患者中可获得一致的高临床妊娠率和低卵巢过度刺激综合征率:一项回顾性多中心研究。
Hum Reprod. 2013 Sep;28(9):2529-36. doi: 10.1093/humrep/det304. Epub 2013 Jul 19.
10
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.一种简化的体外受精促排卵方案通用方法:采用定制的最终卵泡成熟模式和时间的超短激动剂/拮抗剂联合方案。
J Ovarian Res. 2015 Nov 4;8:69. doi: 10.1186/s13048-015-0198-3.

引用本文的文献

1
Intra-abdominal hemorrhage following ultrasound-guided transvaginal oocyte retrieval: Retrospective analysis of 25 cases.超声引导下经阴道取卵术后腹腔内出血:25例回顾性分析
AJOG Glob Rep. 2025 May 21;5(3):100508. doi: 10.1016/j.xagr.2025.100508. eCollection 2025 Aug.
2
Deep Learning Models for Multi-Part Morphological Segmentation and Evaluation of Live Unstained Human Sperm.用于活体未染色人类精子多部分形态学分割与评估的深度学习模型
Sensors (Basel). 2025 May 14;25(10):3093. doi: 10.3390/s25103093.
3
Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis.
体外受精/卵胞浆内单精子注射中优化卵巢刺激的促性腺激素剂量选择模型的开发与验证:一项个体参与者数据荟萃分析
Hum Reprod Update. 2025 Mar 1;31(2):116-132. doi: 10.1093/humupd/dmae032.
4
Informed consent and coercion in recruitment advertisements for oocyte donors.招募卵母细胞捐赠者的广告中的知情同意与强制。
BMC Womens Health. 2024 Sep 20;24(1):526. doi: 10.1186/s12905-024-03302-w.
5
Patient experience of social and medical fertility preservation fully reimbursed in France.法国全额报销社会和医疗生育力保存的患者体验。
J Assist Reprod Genet. 2024 Oct;41(10):2813-2822. doi: 10.1007/s10815-024-03222-6. Epub 2024 Aug 14.
6
Fertility Preservation in Children and Adolescents: Where We Are and Where We Are Going.儿童和青少年的生育力保存:现状与未来。
Curr Urol Rep. 2024 Jul;25(7):133-140. doi: 10.1007/s11934-024-01204-w. Epub 2024 May 10.
7
Haemoperitoneum due to ovarian rupture after oocyte retrieval procedure.取卵术后卵巢破裂致腹腔内出血。
BMJ Case Rep. 2023 Nov 17;16(11):e256591. doi: 10.1136/bcr-2023-256591.
8
Fertility Preservation as an Option for Women with Genetic Disorders: Insights from a SWOT Analysis on Elective Oocyte Freezing and Preimplantation Genetic Testing.为患有遗传疾病的女性保留生育能力的一种选择:对选择性卵母细胞冷冻和植入前基因检测的SWOT分析见解
Life (Basel). 2023 Jun 30;13(7):1483. doi: 10.3390/life13071483.
9
Egg donor self-reports of ovarian hyperstimulation syndrome: severity by trigger type, oocytes retrieved, and prior history.供卵者对卵巢过度刺激综合征的自我报告:按触发类型、采集的卵母细胞和既往史评估严重程度。
J Assist Reprod Genet. 2023 Jun;40(6):1291-1304. doi: 10.1007/s10815-023-02855-3. Epub 2023 Jun 22.
10
Fertility preservation in women with benign gynaecological conditions.患有良性妇科疾病女性的生育力保存
Hum Reprod Open. 2023 Apr 6;2023(2):hoad012. doi: 10.1093/hropen/hoad012. eCollection 2023.